在充分治疗的患者中，罗氟司特不能降低COPD恶化，但亚组分析允许共同决策

Clinical Research In Practice: The Journal of Team Hippocrates Pub Date : 2019-02-06 DOI:10.22237/CRP/1549411200

N. Sánchez

{"title":"在充分治疗的患者中，罗氟司特不能降低COPD恶化，但亚组分析允许共同决策","authors":"N. Sánchez","doi":"10.22237/CRP/1549411200","DOIUrl":null,"url":null,"abstract":"A critical appraisal and clinical application of Martinez FJ, Rabe KF, Sethi S, et al. Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting beta2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial. Am J Respir Crit Care Med. Sep 1 2016;194(5):559-567. doi: <a href=\"https://doi.org/10.1164/rccm.201607-1349OC\">10.1164/rccm.201607-1349OC</a>.","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Roflumilast does not decrease COPD exacerbations in adequately treated patients, but subgroup analysis allows for shared decision making\",\"authors\":\"N. Sánchez\",\"doi\":\"10.22237/CRP/1549411200\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A critical appraisal and clinical application of Martinez FJ, Rabe KF, Sethi S, et al. Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting beta2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial. Am J Respir Crit Care Med. Sep 1 2016;194(5):559-567. doi: <a href=\\\"https://doi.org/10.1164/rccm.201607-1349OC\\\">10.1164/rccm.201607-1349OC</a>.\",\"PeriodicalId\":10422,\"journal\":{\"name\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"volume\":\"4 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22237/CRP/1549411200\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research In Practice: The Journal of Team Hippocrates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22237/CRP/1549411200","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

Martinez FJ, Rabe KF, Sethi S等的关键性评价及临床应用。罗氟米司特和吸入皮质类固醇/长效β -受体激动剂对慢性阻塞性肺疾病加重(RE(2)SPOND)的影响。一项随机临床试验。[J]中华呼吸与急救医学杂志，2016;19(5):559-567。doi: 10.1164 / rccm.201607 - 1349摄氏度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Roflumilast does not decrease COPD exacerbations in adequately treated patients, but subgroup analysis allows for shared decision making

A critical appraisal and clinical application of Martinez FJ, Rabe KF, Sethi S, et al. Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting beta2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial. Am J Respir Crit Care Med. Sep 1 2016;194(5):559-567. doi: 10.1164/rccm.201607-1349OC.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Research In Practice: The Journal of Team Hippocrates

自引率

0.00%

发文量